Characterization of the in vitro metabolic profile of nazartinib in HLMs using UPLC-MS/MS method: In silico metabolic lability and DEREK structural alerts screening using StarDrop software-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of the in vitro metabolic profile of nazartinib in HLMs using UPLC-MS/MS method: In silico metabolic lability and DEREK structural alerts screening using StarDrop software

Published:2024-07 Issue:13 Volume:10 Page:e34109
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Attwa Mohamed W.^ORCID,Abdelhameed Ali S.,Kadi Adnan A.^ORCID

Funder

King Saud University

Publisher

Elsevier BV

Reference55 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Optimization of dosing for EGFR-mutant non–small cell lung cancer with evolutionary cancer modeling;Chmielecki;Sci. Transl. Med.,2011

3. Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK;Katayama;Proc Natl Acad Sci,2011

4. From bench top to bedside;Barinaga;Science,1997

5. MicroRNA function in cancer: oncogene or a tumor suppressor?;Shenouda;Cancer Metastasis Rev.,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP